Literature DB >> 9786870

Processing of an HIV replication intermediate by the human DNA replication enzyme FEN1.

J A Rumbaugh1, G M Fuentes, R A Bambara.   

Abstract

The role of human FEN1 (flap endonuclease-1), an RTH1 (RAD two homolog-1) class nuclease, in the replication of human immunodeficiency virus (HIV) type 1 has been examined using model substrates. FEN1 is able to endonucleolytically cleave a primer annealed to a template, but with a 5'-unannealed tail. The HIV (+)-strand is synthesized as two discontinuous segments, with the upstream segment displacing the downstream segment to form a central (+)-strand overlap. Given a substrate with the exact HIV nucleotide sequence, FEN1 was able to remove the overlap. After extension of the upstream primer with DNA polymerase epsilon, human DNA ligase I was able to complete the continuous double strand as would occur for an integrated provirus. FEN1 may represent a target for new therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9786870     DOI: 10.1074/jbc.273.44.28740

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Repair of gaps in retroviral DNA integration intermediates.

Authors:  K E Yoder; F D Bushman
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  G-quartets assembly within a G-rich DNA flap. A possible event at the center of the HIV-1 genome.

Authors:  Sébastien Lyonnais; Candide Hounsou; Marie-Paule Teulade-Fichou; Josette Jeusset; Eric Le Cam; Gilles Mirambeau
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

Review 3.  Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription.

Authors:  Judith G Levin; Mithun Mitra; Anjali Mascarenhas; Karin Musier-Forsyth
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

4.  Human immunodeficiency virus type 1 central DNA flap: dynamic terminal product of plus-strand displacement dna synthesis catalyzed by reverse transcriptase assisted by nucleocapsid protein.

Authors:  L Hameau; J Jeusset; S Lafosse; D Coulaud; E Delain; T Unge; T Restle; E Le Cam; G Mirambeau
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  Correlates of relative resistance against low-dose rectal simian immunodeficiency virus challenges in peripheral blood mononuclear cells of vaccinated rhesus macaques.

Authors:  Raj Kurupati; Steve Tuyishime; Andrew V Kossenkov; Marina Sazanovich; Larissa H Haut; Marcio O Lasaro; Sarah J Ratcliffe; Steven E Bosinger; Diane G Carnathan; Mark Lewis; Louise C Showe; Guido Silvestri; Hildegund C J Ertl
Journal:  J Leukoc Biol       Date:  2012-12-27       Impact factor: 4.962

6.  HIV-1 exploits the Fanconi anemia pathway for viral DNA integration.

Authors:  Shaozu Fu; An Thanh Phan; Dexin Mao; Xinlu Wang; Guangxia Gao; Stephen P Goff; Yiping Zhu
Journal:  Cell Rep       Date:  2022-05-24       Impact factor: 9.995

7.  The base excision repair pathway is required for efficient lentivirus integration.

Authors:  Kristine E Yoder; Amy Espeseth; Xiao-hong Wang; Qingming Fang; Maria Teresa Russo; R Stephen Lloyd; Daria Hazuda; Robert W Sobol; Richard Fishel
Journal:  PLoS One       Date:  2011-03-23       Impact factor: 3.240

8.  The DNA-protein interaction modes of FEN-1 with gap substrates and their implication in preventing duplication mutations.

Authors:  Ren Liu; Junzhuan Qiu; L David Finger; Li Zheng; Binghui Shen
Journal:  Nucleic Acids Res       Date:  2006-03-31       Impact factor: 16.971

9.  Host proteins interacting with the Moloney murine leukemia virus integrase: multiple transcriptional regulators and chromatin binding factors.

Authors:  Barbara Studamire; Stephen P Goff
Journal:  Retrovirology       Date:  2008-06-13       Impact factor: 4.602

10.  Transcriptional Changes in CD8(+) T Cells During Antiretroviral Therapy Intensified With Raltegravir.

Authors:  Zhengyu Ouyang; Maria J Buzon; Lu Zheng; Hong Sun; Xu G Yu; Ronald J Bosch; John W Mellors; Joseph J Eron; Rajesh T Gandhi; Mathias Lichterfeld
Journal:  Open Forum Infect Dis       Date:  2015-04-01       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.